-
1
-
-
17944362664
-
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)
-
Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005;352:1851-1860.
-
(2005)
N. Engl. J. Med.
, vol.352
, pp. 1851-1860
-
-
Hampel, H.1
Frankel, W.L.2
Martin, E.3
-
2
-
-
35148901553
-
Comment on: Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients
-
Hampel H, Panescu J, Lockman J, et al. Comment on: Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res. 2007;67:9603.
-
(2007)
Cancer Res.
, vol.67
, pp. 9603
-
-
Hampel, H.1
Panescu, J.2
Lockman, J.3
-
3
-
-
58849130663
-
Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: A report of 121 families with proven mutations
-
Barrow E, Robinson L, AlduaijW, et al. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: A report of 121 families with proven mutations. Clin Genet. 2009;75:141-149.
-
(2009)
Clin. Genet.
, vol.75
, pp. 141-149
-
-
Barrow, E.1
Alduaijw, R.L.2
-
4
-
-
0029862873
-
Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis
-
Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020-1027.
-
(1996)
Gastroenterology
, vol.110
, pp. 1020-1027
-
-
Vasen, H.F.1
Wijnen, J.T.2
Menko, F.H.3
-
5
-
-
20544467125
-
Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: Correction for ascertainment
-
Quehenberger F, Vasen HF, van Houwelingen HC. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: Correction for ascertainment. J Med Genet. 2005;42:491-496.
-
(2005)
J. Med. Genet.
, vol.42
, pp. 491-496
-
-
Quehenberger, F.1
Vasen, H.F.2
Van Houwelingen, H.C.3
-
6
-
-
79958071334
-
Cancer risks associated with germline mutations in MLH1 MSH2 and MSH6 genes in Lynch syndrome
-
Bonadona V, Bonaiti B, Olschwang S, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA. 2011;305:2304-2310.
-
(2011)
JAMA
, vol.305
, pp. 2304-2310
-
-
Bonadona, V.1
Bonaiti, B.2
Olschwang, S.3
-
7
-
-
23244443650
-
Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: Later age of onset
-
Hampel H, Stephens JA, Pukkala E, et al. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: Later age of onset. Gastroenterology 2005;129:415-421.
-
(2005)
Gastroenterology
, vol.129
, pp. 415-421
-
-
Hampel, H.1
Stephens, J.A.2
Pukkala, E.3
-
8
-
-
70350090521
-
Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome
-
Stoffel E, Mukherjee B, Raymond VM, et al. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology 2009;137:1621-1627.
-
(2009)
Gastroenterology
, vol.137
, pp. 1621-1627
-
-
Stoffel, E.1
Mukherjee, B.2
Raymond, V.M.3
-
9
-
-
59849129653
-
EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome
-
Palomaki GE, McClain MR, Melillo S, et al. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med. 2009;11:42-65.
-
(2009)
Genet. Med.
, vol.11
, pp. 42-65
-
-
Palomaki, G.E.1
McClain, M.R.2
Melillo, S.3
-
10
-
-
76349108011
-
Risks of Lynch syndrome cancers for MSH6 mutation carriers
-
Baglietto L, Lindor NM, Dowty JG, et al. Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst. 2010;102:193-201.
-
(2010)
J. Natl. Cancer Inst.
, vol.102
, pp. 193-201
-
-
Baglietto, L.1
Lindor, N.M.2
Dowty, J.G.3
-
11
-
-
48549099663
-
The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations
-
Senter L, Clendenning M, Sotamaa K, et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 2008;135:419-428.
-
(2008)
Gastroenterology
, vol.135
, pp. 419-428
-
-
Senter, L.1
Clendenning, M.2
Sotamaa, K.3
-
12
-
-
84860605783
-
Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: A prospective cohort study
-
Win AK, Young JP, Lindor NM, et al. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: A prospective cohort study. J Clin Oncol. 2012;30: 958-964.
-
(2012)
J. Clin. Oncol.
, vol.30
, pp. 958-964
-
-
Win, A.K.1
Young, J.P.2
Lindor, N.M.3
-
13
-
-
0019515269
-
The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre's syndrome
-
Lynch HT, Lynch PM, Pester J, et al. The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre's syndrome. Arch Intern Med. 1981;141:607-611.
-
(1981)
Arch. Intern. Med.
, vol.141
, pp. 607-611
-
-
Lynch, H.T.1
Lynch, P.M.2
Pester, J.3
-
14
-
-
39649093644
-
The frequency of Muir-Torre syndrome among Lynch syndrome families
-
South CD, Hampel H, Comeras I, et al. The frequency of Muir-Torre syndrome among Lynch syndrome families. J Natl Cancer Inst. 2008;100:277-281.
-
(2008)
J. Natl. Cancer Inst.
, vol.100
, pp. 277-281
-
-
South, C.D.1
Hampel, H.2
Comeras, I.3
-
16
-
-
0025848680
-
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)
-
Vasen HF, Mecklin JP, Khan PM, et al The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum. 1991;34:424-425.
-
(1991)
Dis Colon Rectum.
, vol.34
, pp. 424-425
-
-
Vasen, H.F.1
Mecklin, J.P.2
Khan, P.M.3
-
17
-
-
0033063711
-
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC
-
Vasen HF,Watson P, Mecklin JP, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999;116:1453-1456.
-
(1999)
Gastroenterology
, vol.116
, pp. 1453-1456
-
-
Vasen Hfwatson, P.1
Mecklin, J.P.2
-
18
-
-
0031551963
-
A National cancer institute workshop on hereditary nonpolyposis colorectal cancer syndrome: Meeting highlights and bethesda guidelines
-
Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting highlights and Bethesda guidelines. J Natl Cancer Inst. 1997;89:1758-1762.
-
(1997)
J. Natl. Cancer Inst.
, vol.89
, pp. 1758-1762
-
-
Rodriguez-Bigas, M.A.1
Boland, C.R.2
Hamilton, S.R.3
-
19
-
-
10744233937
-
Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability
-
Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261-268.
-
(2004)
J. Natl. Cancer Inst.
, vol.96
, pp. 261-268
-
-
Umar, A.1
Boland, C.R.2
Terdiman, J.P.3
-
20
-
-
80054081678
-
Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: From the revised Bethesda guidelines to a universal approach
-
Morrison J, Bronner M, Leach BH, et al. Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: From the revised Bethesda guidelines to a universal approach. Scand J Gastroenterol. 2012;46:1340-1348.
-
(2012)
Scand. J. Gastroenterol.
, vol.46
, pp. 1340-1348
-
-
Morrison, J.1
Bronner, M.2
Leach, B.H.3
-
21
-
-
77954720070
-
Clinical relevance of microsatellite instability in colorectal cancer
-
de la Chapelle A, Hampel H. Clinical relevance of microsatellite instability in colorectal cancer. J Clin Oncol. 2010;28:3380-3387.
-
(2010)
J. Clin. Oncol.
, vol.28
, pp. 3380-3387
-
-
De La Chapelle, A.1
Hampel, H.2
-
22
-
-
0032534069
-
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
-
Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248-5257.
-
(1998)
Cancer Res.
, vol.58
, pp. 5248-5257
-
-
Boland, C.R.1
Thibodeau, S.N.2
Hamilton, S.R.3
-
23
-
-
57449097359
-
Feasibility of screening for Lynch syndrome among patients with colorectal cancer
-
Hampel H, Frankel WL, Martin E, et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol. 2008;26:5783-5788.
-
(2008)
J. Clin. Oncol.
, vol.26
, pp. 5783-5788
-
-
Hampel, H.1
Frankel, W.L.2
Martin, E.3
-
24
-
-
0034799747
-
The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer
-
Samowitz WS, Curtin K, Lin HH, et al. The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology 2001;121:830-838.
-
(2001)
Gastroenterology
, vol.121
, pp. 830-838
-
-
Samowitz, W.S.1
Curtin, K.2
Lin, H.H.3
-
26
-
-
70449536487
-
Epitope-positive truncating MLH1 mutation and loss of PMS2: Implications for IHC-directed genetic testing for Lynch syndrome
-
Zighelboim I, Powell MA, Babb SA, et al. Epitope-positive truncating MLH1 mutation and loss of PMS2: Implications for IHC-directed genetic testing for Lynch syndrome. Fam Cancer. 2009;8:501-504.
-
(2009)
Fam. Cancer
, vol.8
, pp. 501-504
-
-
Zighelboim, I.1
Powell, M.A.2
Babb, S.A.3
-
27
-
-
0037083484
-
Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors
-
Lindor NM, Burgart LJ, Leontovich O, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol. 2002;20:1043-1048.
-
(2002)
J. Clin. Oncol.
, vol.20
, pp. 1043-1048
-
-
Lindor, N.M.1
Burgart, L.J.2
Leontovich, O.3
-
28
-
-
12244278227
-
Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours
-
Ruszkiewicz A, Bennett G, Moore J, et al. Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours. Pathology 2002;34:541-547.
-
(2002)
Pathology
, vol.34
, pp. 541-547
-
-
Ruszkiewicz, A.1
Bennett, G.2
Moore, J.3
-
29
-
-
34547405167
-
Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer
-
Loughrey MB, Waring PM, Tan A, et al. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Fam Cancer. 2007;6:301-310.
-
(2007)
Fam. Cancer
, vol.6
, pp. 301-310
-
-
Loughrey, M.B.1
Waring, P.M.2
Tan, A.3
-
30
-
-
72749085056
-
Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer
-
Hitchins MP, Ward RL. Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer. J Med Genet. 2009;46:793-802.
-
(2009)
J. Med. Genet.
, vol.46
, pp. 793-802
-
-
Hitchins, M.P.1
Ward, R.L.2
-
31
-
-
2342439022
-
RAS/RAF mutation and defective DNA mismatch repair in endometrial cancers
-
Mutch DG, Powell MA, Mallon MA, et al. RAS/RAF mutation and defective DNA mismatch repair in endometrial cancers. Am J Obstet Gynecol. 2004;190:935-942.
-
(2004)
Am. J. Obstet. Gynecol.
, vol.190
, pp. 935-942
-
-
Mutch, D.G.1
Powell, M.A.2
Mallon, M.A.3
-
32
-
-
79952183867
-
Genetic counseling considerations in the evaluation of families for Lynch syndromeVa review
-
Weissman SM, Bellcross C, Bittner CC, et al. Genetic counseling considerations in the evaluation of families for Lynch syndromeVa review. J Genet Couns. 2011;20:5-19.
-
(2011)
J. Genet. Couns.
, vol.20
, pp. 5-19
-
-
Weissman, S.M.1
Bellcross, C.2
Bittner, C.C.3
-
33
-
-
59849108362
-
Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives
-
Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med. 2009;11:35-41.
-
(2009)
Genet. Med.
, vol.11
, pp. 35-41
-
-
-
34
-
-
77149122082
-
The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer
-
Mvundura M, Grosse SD, Hampel H, et al. The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med. 2010;12:93-104.
-
(2010)
Genet. Med.
, vol.12
, pp. 93-104
-
-
Mvundura, M.1
Grosse, S.D.2
Hampel, H.3
-
35
-
-
79960604164
-
Strategies to identify the Lynch syndrome among patients with colorectal cancer: A cost-effectiveness analysis
-
Ladabaum U,Wang G, Terdiman J, et al. Strategies to identify the Lynch syndrome among patients with colorectal cancer: A cost-effectiveness analysis. Ann Intern Med. 2011;155:69-79.
-
(2011)
Ann Intern Med.
, vol.155
, pp. 69-79
-
-
Ladabaum Uwang, G.1
Terdiman, J.2
-
36
-
-
67650383819
-
Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome
-
Niessen RC, Hofstra RM, Westers H, et al. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome. Genes Chromosomes Cancer. 2009;48:737-744.
-
(2009)
Genes Chromosomes Cancer.
, vol.48
, pp. 737-744
-
-
Niessen, R.C.1
Hofstra, R.M.2
Westers, H.3
-
37
-
-
70350439453
-
Ten years after mutation testing for Lynch syndrome: Cancer incidence and outcome in mutation-positive and mutation-negative family members
-
Jarvinen HJ, Renkonen-Sinisalo L, Aktan-Collan K, et al. Ten years after mutation testing for Lynch syndrome: Cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol. 2009;27:4793-4797.
-
(2009)
J. Clin. Oncol.
, vol.27
, pp. 4793-4797
-
-
Jarvinen, H.J.1
Renkonen-Sinisalo, L.2
Aktan-Collan, K.3
-
38
-
-
84864583824
-
-
NCCN. NCCN Guidelines Version 1.2012: Colorectal Cancer Screening [v.1.2012].
-
NCCN. NCCN Guidelines Version 1.2012 Colorectal Cancer Screening. NCCN Guidelines for Detection, Prevention, and Risk Reduction [v.1.2012]. 2012.
-
(2012)
NCCN Guidelines for Detection Prevention and Risk Reduction
-
-
-
39
-
-
83955161674
-
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial
-
Burn J, Gerdes AM, Macrae F, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial. Lancet. 378:2081-2087.
-
Lancet
, vol.378
, pp. 2081-2087
-
-
Burn, J.1
Gerdes, A.M.2
MacRae, F.3
|